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  Cocaine is widely assumed to be a risk factor for stroke, yet good scientific evidence for a 
causal association between the use of cocaine and ischemic stroke is not as clear as commonly 
held.  Cocaine use is widespread.  In 2013, an estimated 24.6 million Americans, approximately 
9% of the population aged 12 or older, had used an illicit drug in the past month.1  While the 
majority was using marijuana, past month cocaine intake was still reported by 1.5% of the US 
population.1 
     A similarly high use of cocaine was also found in a population-based case-control study by 
Cheng et al., reporting, in the current issue of Stroke, on the association of cocaine exposure 
and risk of ischemic stroke, from “The Stroke Prevention in Young Adults Study”.2  In their study 
population, derived from the greater Baltimore/Washington DC area, a quarter of subjects with 
recent ischemic stroke (cases), between the ages 15-49, were found to have previously used 
cocaine.  An equally high prevalence of having ever used cocaine was recorded in an age-, 
gender-, race- and geographically- matched control group of stroke-free subjects.  Subjects with 
stroke, however, were more likely to have used cocaine more than once per week in the past 
year and the odds of having used cocaine in the 24h prior to stroke onset were approximately 6 
times higher in cases, when compared to a reference date for controls.  This led the authors to 
conclude that the risk of ischemic stroke is highest in the first few hours after cocaine 
consumption, the period most likely to be of biological relevance. 
     But how does one reconcile these findings?  Even if the risk for ischemic stroke is restricted 
to the first few hours after cocaine exposure, why does this not translate into an increased risk 
for stroke in those having ever tried cocaine?  Some of the answers may lie within the limitations 
of a case-control study.  Overall, the risk of cocaine and ischemic stroke seems to be quite low, 
given the widespread exposure to the risk factor.  The authors commendably acknowledge 
several limitations to their study, including the small sample size and the inadequate control for 
cofounding factors such as amount of smoking and alcohol intake, which casts doubt on the 
isolated role of cocaine in promoting stroke and raises the question of other vascular risk factors 
to potentiate the risk of cocaine-related stroke.  
     The authors also point out that the selection of the reference day for cocaine use in the 
control group, was a limitation to their findings.  In the stroke cases, the reference date is clearly 
defined as the date of stroke.  In the control group, the reference date for cocaine use was, in 
the early study period, the date of the interview.  The authors speculate that knowledge of the 
pending interview, scheduled in advance, could have affected any drug related behavior in the 
days preceding the interview.  Along similar lines, the interview was likely scheduled during 
regular working days, and any increased cocaine use during holidays and weekends may have 
been also missed in this manner.  All this could have led to an under-reporting of acute cocaine 
use in the control group.   
     While this does not refute the fact that fewer controls used cocaine acutely and were less 
likely to have stroke, influencing subject behavior in an observational study always raises the 
concern for introducing bias.  The authors subsequently adjusted the reference date to match 
the weekday that the stroke occurred in a matched case.  The subgroup analysis of this optimal 
data set did not find an effect of cocaine use in the acute setting, suggesting perhaps that the 
risk of stroke with cocaine use is more tenuous than previously accepted.   
     The authors raise the possibility that other factors might augment the risk of ischemic stroke 
with cocaine.  A review of the characteristics of the 26 stroke patients who had used cocaine in 
the 24h prior to stroke, shows that all had at least one vascular risk factor and almost a quarter 
had pre-existing cardiac pathology.  Unfortunately, due to sample size limitations this could not 
be explored further.  Also of note is that the subjects with stroke and cocaine were virtually all in 
their late thirties and forties, with the overall study inclusion criteria ranging between the ages of 
15-49. The mean age, however does not appear to be much different than the stroke-case 
group as a whole (39.8 vs. 40.9 years).  Interestingly, in 2013 the average age of first cocaine 
use among 12 to 49 years olds was 20 years.1  The fact that none of the stroke patients with 
acute cocaine use was in their teens or twenties, and that all had vascular risk factors certainly 
suggests that acute use of cocaine entails a very low risk of cerebral infarction in a young 
otherwise healthy person.  The issue gets further complicated by the frequent use of cocaine in 
the 26 patients who reported acute cocaine use and stroke.  Over half were using cocaine daily 
and many several times daily, thus blurring perhaps the definition for acute use.  The fact that 
the case group as a whole seemed to report more frequent consumption of cocaine also raises 
the possibility of a dose effect.  Alternatively, it may have been difficult to find appropriate 
controls from a population of more active daily cocaine users, who may not have been as 
accessible for contact and consent to the study.   
    This may be a potential source of bias, and also warrants careful interpretation of the author’s 
findings.  The absence of graded exposure data for tobacco, alcohol, or other illicit drug use, 
hypertension or diabetes is another major caveat, since the cocaine exposure data alone 
indicate a pattern of poor cardiovascular risk across multiple major risk factors, and cocaine use 
may simply represent a surrogate for general neglect of health. Information on treatment for the 
risk factors that are documented is not given. 
If cocaine is a significant risk factor for ischemic stroke then a more specific mechanistic 
relationship should perhaps be evident, yet the pattern of ischemic events is not different from 
younger adults in general, with a range of mechanisms and predominance of cardioembolism 
and “cryptogenic” stroke. It is possible that the cocaine history influenced the extent of 
investigation, but nonetheless it is notable that a clear mechanism is lacking. If hypertension 
consequent to sympathomimetic effects is the most relevant mechanism, then a relationship 
with intracerebral hemorrhage should also be found, and this was unfortunately not explored in 
the current study. CNS vasculitis, often attributed to cocaine use, is absent from the list of 
mechanisms.  
      The article by Cheng et al. contributes to the existing literature and advances our 
understanding of the role of cocaine in stroke.  It is difficult to argue against their concluding 
recommendations to screen young stroke patients for cocaine use.  This would allow timely 
interventions on drug counselling and rehabilitation.  However some of their finding should make 
us question the commonly held belief of cocaine as a robust risk factor for ischemic stroke.  
Clearly there is more behind the story.  The manner of cocaine ingestion, dose effect, and 
potential contaminants are likely additional factors of importance, but will probably never be 
known in most cases. How these interact with individual predispositions, particularly age and 
other vascular risk factors, will ultimately define the true risk of cocaine and stroke and the 
pathophysiological mechanisms involved.   
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